Pruritic Papular Eruption in HIV

Dermatologic Clinics

Volumn 24, Issue 4, 2006, Pages 449-457

  Eisman, Samantha ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIPRURITIC AGENT; CORTICOSTEROID; CYTOKINE; EMOLLIENT AGENT; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 5;

ACANTHOSIS; ARTHROPOD; B LYMPHOCYTE; BLOOD EXAMINATION; CELL CULTURE; CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERKERATOSIS; IMMUNOLOGICAL PROCEDURES; PAPULAR RASH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; REVIEW; T LYMPHOCYTE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

DIAGNOSIS, DIFFERENTIAL; HIV INFECTIONS; HUMANS; PRURITUS; SKIN DISEASES, PAPULOSQUAMOUS;

EID: 33748924304     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2006.06.005     Document Type: Review

References (54)

1. Fisher B.K., and Warner L.C. Cutaneous manifestations of the acquired immunodeficiency syndrome. Int J Dermatol 26 (1987) 262-264
2. Rosatelli J.B., Machado A.A., and Roselino A.M.F. Dermatoses among Brazilian HIV-positive patients: correlation with the evolutionary phases of AIDS. Int J Dermatol 36 (1997) 729-734
3. Colebunders R., Mann J.M., Francis H., et al. Generalized papular pruritic eruptions in African patients with HIV infection. AIDS 1 (1987) 117-121
4. Hira S.K., Wadhawan D., Kamanga J., et al. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia. J Am Acad Dermatol 19 (1988) 451-457
5. Bason M.M., Berger T.G., and Nesbitt Jr. L.T. Pruritic papular eruption of HIV-disease. Int J Dermatol 32 (1993) 784-789
6. Liautaud B., Pape J.W., and DeHovitz J.A. Pruritic skin lesions: a common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 125 (1989) 629-632
7. Piot P., Taelman H., and Minlangu K.B. Acquired immunodeficiency syndrome in the heterosexual population in Zaire. Lancet 2 (1984) 65-68
8. Van de Perre P., Lepage P., Kestelyn P., et al. Acquired immunodeficiency syndrome in Rwanda. Lancet 2 (1984) 62-65
9. Serwadda D., Sewankambo N.K., Carswell J.W., et al. Slim disease: a new disease in Uganda and its associations with HTLV-III infection. Lancet 2 (1985) 849-852
10. Resneck J.S., Van Beek M., Furmanski L., et al. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA 292 (2004) 2614-2621
11. Mahe A., Simon F., Couilbaly S., et al. Predictive value of seborrheic dermatitis and other common dermatoses for HIV infection in Bamoko, Mali. J Am Acad Dermatol 34 (1996) 1084-1086
12. Pallangyo K.J. Cutaneous findings associated with HIV disease including AIDS: experience from sub-Saharan Africa. Trop Doct 22 (1992) 35-41
13. Olumide Y.M., Dada A.J., Sogbanmu I.B., et al. Seroprevalence study of HIV-I, HIV-II, and HTLV-I among patients at the Dermato-Venereology Clinic of the Lagos University Teaching Hospital. Int J Dermatol 36 (1997) 741-744
14. Pitche P., Tchangai-Walla K., Napo-Koura G., et al. [Prevalence of skin manifestations in AIDS patients in the Lome-Tokoin University Hospital (Togo)]. Sante 5 (1995) 349-352 [in French]
15. Aires J.M., Rosatelli J.B., de Castro Figueiredo J.F., et al. Cytokines in the pruritic papular eruption of HIV. Int J Dermatol 39 (2000) 903-906
16. Boonchai W.B., Laohasrisakul R., Manonukul J., et al. Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression. Int J Dermatol 38 (1999) 348-350
17. Hevia O., Jimenez-Acosta F., Ceballos P.I., et al. Pruritic papular eruption of the acquired immunodeficiency syndrome: a clinicopathologic study. J Am Acad Dermatol 24 (1991) 231-235
18. Goldstein B., Berman B., Sukenik E.A., et al. Correlation of skin disorders with CD4-lymphocyte counts in patients with HIV/AIDS. J Am Acad Dermatol 36 (1997) 262-264
19. Smith K.J., Skelton H.G., Yeager J., et al. Increased drug reactions in HIV-1 positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. Clin Exp Dermatol 22 (1997) 118-123
20. Pirmohamed M., and Park B.K. HIV and drug allergy. Curr Opin Allergy Clin Immunol 1 (2001) 311-316
21. Penneys N.S., Nayar J.K., Bernstein H., et al. Chronic pruritic eruption in patients with acquired immunodeficiency syndrome associated with increased antibody titers to mosquito salivary antigens. J Am Acad Dermatol 21 (1989) 421-425
22. Broide D.H. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 108 2 (2001) 565-571
23. Palungwachira P., Chirachanakul P., Palungwachira P., et al. Cutaneous findings in HIV-1 positive patients in Thailand. J Dermatol 28 (2000) 584-585
24. Skiest D.J., and Keiser P. Clinical significance of eosinophilia in HIV-infected individuals. Am J Med 102 (1997) 449-453
25. James W.D., and Redfield R.R. Human immunodeficiency virus infection and skin disease. J Assoc Mil Dermatol 2 (1987) 7-12
26. Duvic M. Staphylococcal infections and the pruritus of AIDS-related complex. Arch Dermatol 123 (1987) 1599
27. Rosenthal D., LeBoit P.E., Klumpp L., et al. Human immunodeficiency virus-associated eosinophilic folliculitis. Arch Dermatol 127 (1991) 206-209
28. Kinloch-de Loes S., Didierjean L., Rieckerhoff-Cantoni L., et al. Bullous pemphigoid autoantibodies, HIV-infection and pruritic papular eruption. AIDS 5 (1991) 451-454
29. Gelfand J.M., and Rudikoff D. Evaluation and treatment of itching in HIV-infected patients. Mt Sinai J Med 68 (2001) 298-308
30. Rosatelli J.B., Soares F.A., and Roselino A.M.F. Pruritic papular eruption of the acquired immunodeficiency syndrome: predominance of CD8 + cells. Int J Dermatol 39 (2000) 873-874
31. Ramos H., Pagliari C., Takakura C.F., et al. Pruritic papular eruption associated with HIV etiopathogenesis evaluated by clinical, immunohistochemical, and ultrastructural analysis. J Dermatol 32 (2005) 549-556
32. Pardo R.J., Bogaert M.A., Penneys N.S., et al. UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndrome. J Am Acad Dermatol 26 (1992) 423-428
33. Sanchez M., Fotiades J., Soter N.A., et al. The characterization of HIV-associated papular eruptions. [abstract PO-B20-1873]. Int Conf AIDS 9 (1993) 447
34. Caterino-de-Araujo A. HIV-1 infection and eosinophilia. Immunol Today 15 (1994) 498-499
35. Teofoli P., Barbieri C., Pallotta S., et al. Pruritic eosinophilic papular eruption revealing HIV infection. Eur J Dermatol 12 (2002) 600-602
36. Majors M.J., Berger T.G., Blauvelt A., et al. HIV-related eosinophilic folliculitis: a panel discussion. Semin Cutan Med Surg 16 (1997) 219-223
37. Rajendran P.M., Dolev J.C., HEaphy M.R., et al. Eosinophilic folliculitis. Before and after the introduction of antiretroviral therapy. Arch Dermatol 141 (2005) 1227-1231
38. Buchness M.R., Gregory N., Lim H.W., et al. The role of mast cells and eosinophils in eosinophilic pustular folliculitis of the acquired immunodeficiency syndrome. [abstract]. J Invest Dermatol 92 (1989) 408
39. Schnoll S., Sanchez M., and Reisfeld P. Rapid diagnosis of HIV-associated eosinophilic pustular folliculitis. [abstract PB0749]. Int Conf AIDS 10 (1994) 184
40. Amerio P., Verdolini R., Proietto G., et al. Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis. Acta Derm Venereol (Stockh) 82 (2001) 92-95
41. Clerici M., and Shearer G.M.A. Th1/Th2 switch is a critical step in the etiology of HIV-infection. Immunol Today 14 (1993) 107-111
42. Illis E., and Scheinfield N. Eosinpohilic pustular folliculitis: a comprehensive review of treatment options. Am J Clin Dermatol 5 (2004) 189-197
43. Toutous-Trellu L., Abraham S., Pechère M., et al. Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection. Arch Dermatol 141 (2005) 1203-1208
44. Ashack R.J., Frost M.L., and Norins A.L. Papular pruritic eruption of Demodex folliculitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 21 (1989) 306-307
45. Berger T.G., Hoffman C., and Thieberg M.D. Prurigo nodularis and photosensitivity in AIDS: treatment with thalidomide. J Am Acad Dermatol 33 (1995) 837-838
46. Raviglione M.C., Mariuz P., Pablos-Mendez, et al. High Staphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS-related complex. Am J Infect Control 18 (1990) 64-69
47. Dominiguez Aunon J.D., Postigo Lorente C., Llamas Martin R., et al. Lichen myxedematous associated with human immunodeficiency virus infection-report of two cases and review of the literature. Clin Exp Dermatol 22 (1997) 265-268
48. Ishii N., Nishiyama T., Sugita Y., et al. Pruritic papular eruption of the acquired immunodeficiency syndrome. Acta Derm Venereol 74 (1994) 219-220
49. Fischer T. UV-light treatment of psoriasis. Acta Derm Venereol (Stockh) 56 (1976) 473-479
50. Scheiber A., Hollis D.E., McCarthy W., et al. Effects of sunlight on Langerhans cells and Rmelanocytes in human epidermis. Photodermatol 3 (1986) 15-21
51. Valerie K., Delers A., Bruck C., et al. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature 333 (1988) 78-81
52. Cavard C., Zider A., Vernet M., et al. In vivo activation of human immunodeficiency virus type 1 long terminal repeat. J Clin Invest 86 (1990) 1369-1374
53. Meola T., Soter N.A., Ostreicher R., et al. The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol 29 (1993) 216-220
54. Berman B., Flores F., and Burke G. Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons. J Am Acad Dermatol 38 (1998) 955-959